Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis

…, RA Sinico, CA Stegeman, KW Westman… - Journal of the …, 2007 - journals.lww.com
Systemic vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens (ANCA)
is the most frequent cause of rapidly progressive glomerulonephritis. Renal failure at …

[HTML][HTML] Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

…, D Walsh, M Walsh, K Westman… - … England Journal of …, 2010 - Mass Medical Soc
Background Cyclophosphamide induction regimens for antineutrophil cytoplasmic antibody
(ANCA)–associated vasculitis are effective in 70 to 90% of patients, but they are associated …

[HTML][HTML] A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

…, C Siegert, A Sinico, V Tesar, K Westman… - … England Journal of …, 2003 - Mass Medical Soc
Background The primary systemic vasculitides usually associated with autoantibodies to
neutrophil cytoplasmic antigens include Wegener's granulomatosis and microscopic polyangiitis…

EULAR recommendations for the management of primary small and medium vessel vasculitis

…, DGI Scott, C Stegeman, R Watts, K Westman… - Annals of the …, 2009 - ard.bmj.com
Objectives: To develop European League Against Rheumatism (EULAR) recommendations
for the management of small and medium vessel vasculitis. Methods: An expert group (…

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody—associated vasculitis: a randomized trial

…, RA Sinico, V Tesar, P Vanhille, K Westman… - Annals of internal …, 2009 - acpjournals.org
Background: Current therapies for antineutrophil cytoplasmic antibody (ANCA)–associated
vasculitis are limited by toxicity. Objective: To compare pulse cyclophosphamide with daily …

Long-term patient survival in ANCA-associated vasculitis

…, C Stegeman, M Walsh, K Westman… - Annals of the …, 2011 - ard.bmj.com
Background Wegener's granulomatosis and microscopic polyangiitis are antineutrophil
cytoplasm antibodies (ANCA)-associated vasculitides with significant morbidity and mortality. …

EULAR recommendations for the management of large vessel vasculitis

…, DGI Scott, C Stegeman, R Watts, K Westman… - Annals of the …, 2009 - ard.bmj.com
Objectives: To develop European League Against Rheumatism (EULAR) recommendations
for the management of large vessel vasculitis. Methods: An expert group (10 rheumatologists…

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up

…, M Walsh, P Hoglund, K Westman… - Annals of the …, 2012 - ard.bmj.com
Introduction The previously reported randomised controlled trial of a consensus regimen of
pulse cyclophosphamide suggested that it was as effective as a daily oral (DO) …

Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis

…, O Flossmann, A Berden, K Westman… - Arthritis & …, 2012 - Wiley Online Library
Objective To determine the association between characteristics at diagnosis and the time to
first relapse in a large cohort of patients with antineutrophil cytoplasmic antibody–associated …

Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg–Strauss syndrome and polyarteritis nodosa

AJ Mohammad, LTH Jacobsson, KWA Westman… - …, 2009 - academic.oup.com
Objective. To estimate the incidence of and survival rates for WG, microscopic polyangiitis (MPA),
Churg–Strauss syndrome (CSS) and PAN within a defined population in southern …